Skip to main content

Table 1 Baseline sociodemographic and biobehavioral characteristics of WIHS participants

From: Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy

Factor N = 2601
Socio-demographic and study characteristics
Median age (IQR) 40.5 (34.5, 47.1)
Race/ethnicity
 African American, non-Hispanic 1632 (63)
 Latina/Hispanic 574 (22)
 White, non-Hispanic 317 (12)
 Asian/Pacific Islander/Native American or Alaskan/Other 78 (3)
Enrollment wave
 Wave 1: 1994–1995 1230 (47)
 Wave 2: 2001–2002 617 (24)
 Wave 3: 2011–2012 230 (8)
 Wave 4: 2013–2015 524 (20)
Less than high school education 949 (36)
Married or partnered 863 (33)
Unstable housing 140 (5)
Unemployed 1754 (67)
Annual household income ≤$24,000 2057 (79)
No health insurance 241 (9)
Pregnant in past 6 months 114 (4)
Mental Health
Depressive symptoms (CES-D score ≥ 16) 1043 (40)
Substance Use
Current smoker 1196 (46)
Alcohol use
 None 1401 (54)
 Low (> 0–7 drinks per week) 965 (37)
 Moderate (> 7–12 drinks per week) 97 (4)
 Heavy (> 12 drinks per week) 138 (5)
Non-injection drug use 617 (24)
Injection drug use
 Never 2018 (78)
 Former 528 (20)
 Current 55 (2)
Medical injection experience
 Insulin use (medical injection)
  Never 2525 (97)
  Former 15 (1)
  Current 61 (2)
 Depo medroxyprogesterone acetate use (medical injection)
  Never 2300 (88)
  Former 156 (6)
  Current 145 (6)
Adherence and viral suppression
  ≥ 75% adherence reported 2135 (82)
 HIV RNA ≤80 copies/ml 1370 (53)